Full Text
The Full Text of this article is available as a PDF (235.9 KB).
References
- 1. Blann AD, Taberner DA: A reliable marker of endothelial cell dysfunction: Does it exist? Br J Haematol 1995; 90: 244–248 [DOI] [PubMed] [Google Scholar]
- 2. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635–641 [DOI] [PubMed] [Google Scholar]
- 3. Boffa MC: Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker. Haemostasis 1996: 26 (suppl 4); 233–243 [DOI] [PubMed] [Google Scholar]
- 4. Blann AD, Amiral J, McCollum CN: Prognostic value of increased soluble thrombomodulin and increased soluble E‐selectin in ischaemic heart disease. Eur J Haem 1997; 58 (in press) [DOI] [PubMed] [Google Scholar]
- 5. Belch JJF, Shaw JW, Kirk G, McLaren M, Robb R, Maple C, Morse P: The white blood cell adhesion molecule E‐selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 1997; 95: 2027–2031 [DOI] [PubMed] [Google Scholar]